The conference will bring together clinicians, researchers, and young investigators to present and discuss current approaches and future directions for translating science to therapy for incontinentia pigmenti (IP). Our goal is to advance our ability to diagnose and manage this rare disease through the development of screening guidelines, effective diagnostics, and novel therapies.
Sponsored by: National Federation of Ectodermal Dysplasia